(Q45244983)

11 December 2017

Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteries (English)

1 reference

11 December 2017

1 reference

Hong Chai

1

1 reference

11 December 2017

Wei Zhou

2

1 reference

11 December 2017

Peter Lin

3

1 reference

11 December 2017

Alan Lumsden

4

1 reference

11 December 2017

Qizhi Yao

5

1 reference

11 December 2017

Changyi Chen

6

1 reference

11 December 2017

28 January 2005

1 reference

American Journal of Physiology Heart and Circulatory Physiology

11 December 2017

1 reference

11 December 2017

288

1 reference

11 December 2017

6

1 reference

11 December 2017

H2965-71

1 reference

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with hiv infection receiving highly active antiretroviral therapy

11 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Cardiovascular protection by ginsenosides and their nitric oxide releasing action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

HIV protease inhibitor ritonavir decreases endothelium-dependent vasorelaxation and increases superoxide in porcine arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Cardiovascular effects of antiretroviral therapy and noninvasive assessments of cardiovascular disease in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Antioxidants and atherosclerotic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Red wine prevents homocysteine-induced endothelial dysfunction in porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Panax ginseng pharmacology: a nitric oxide link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Can ginsenosides protect human erythrocytes against free-radical-induced hemolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Hiv Tat protein causes endothelial dysfunction in porcine coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Modulating angiogenesis: the yin and the yang in ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Estrogen blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries(1,2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Coronary Heart Disease in HIV-Infected Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Nitric oxide: implications for vascular and endovascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Nitric oxide and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Atherosclerosis and the two faces of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01271.2004

10.1152/AJPHEART.01271.2004

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference